Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (1y) (2018 - 2025)
Autolus Therapeutics (AUTL) Cash from Investing Activities Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Autolus Therapeutics | 393.78 Mn | 93.07 Mn | -1.04 Mn | 122.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122.56% |
| Sep 30, 2025 | 470.71% |
| Jun 30, 2025 | 11,504.88% |
| Mar 31, 2025 | -11,072.05% |
| Dec 31, 2024 | -25,870.82% |
| Sep 30, 2024 | -540.12% |
| Jun 30, 2024 | 80.84% |
| Mar 31, 2024 | 85.28% |
| Dec 31, 2023 | -133.33% |
| Sep 30, 2023 | 77.96% |
| Jun 30, 2023 | -66.25% |
| Mar 31, 2023 | -369.78% |
| Dec 31, 2022 | 60.06% |
| Sep 30, 2022 | -76.04% |
| Jun 30, 2022 | -74.72% |
| Mar 31, 2022 | 59.42% |
| Dec 31, 2021 | 71.03% |
| Sep 30, 2021 | 4.64% |
| Jun 30, 2021 | 40.11% |
| Mar 31, 2021 | 27.95% |